Publication | Closed Access

Anti-albuminuric effect of the aldosterone blocker eplerenone in non-diabetic hypertensive patients with albuminuria: a double-blind, randomised, placebo-controlled trial

Metabolic SyndromeHypertensionAldosterone Blocker EplerenoneRenal FunctionCardiovascular DiseaseAnti-albuminuric EffectAntihypertensive TherapyDiabetesPharmacologyPlacebo-controlled TrialPharmacotherapyMedicineEndocrine Hypertension